Linked Life Data

15286825

Source:http://linkedlifedata.com/resource/pubmed/id/15286825

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-8-2
pubmed:abstractText
This report describes three elderly patients with mucosal form of American tegumentary leishmaniasis associated with chronic cardiopathy. Due to the known toxicity of classical drugs with activity against Leishmania sp., the patients received three oral courses of azithromycin therapy in single 500 mg daily dose during ten days, every other month. All lesions healed after the third series. One of the patients relapsed and a new series of azithromycin was prescribed. Azithromycin may be an alternative drug for the treatment of leishmaniasis in special situations due to its optimal mucosal and intraphagocyte concentration, single daily posology, high tolerance and oral administration. The mechanism of this drug on Leishmania sp. is unknown at present.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0036-4665
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
175-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Azithromycin in the treatment of mucosal leishmaniasis.
pubmed:affiliation
Departamento de Clínica Médica, Faculdade de Medicina do Triângulo Mineiro, Uberaba, MG, Brazil. dip_fmtm@mednet.com.br
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't